TP53 and neoplasm: In light of emerging evidence implicating m6A mRNA modifications in gliomagenesis29,30, we examined whether mutant p53-regulated YTHDF2 expression contributes to LFS astrocyte-associated cell proliferation and neoplastic transformation, an oncogenic event that occurs during the early stages of tumor initiation.